This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Influenza

  1. Dr. Le Van Be, director of the Institute of Vaccines and Medical Biologicals, believes in the power of vaccines. And he is committed to seeing locally made influenza vaccine become a reality.
    Published: September 2018
    Type: Article
  2. What's it like to volunteer for for a clinical trial? One participant in Vietnam reflects on the opportunity to contribute to the country's influenza defenses.
    Published: September 2018
    Type: Article
  3. Serbia’s Institute of Virology, Vaccines, and Sera “Torlak” is a trusted, recognized vaccine producer in Serbia. As part of the influenza vaccine development project, it conducted its first complex vaccine clinical trial in humans, which helps position Torlak as an essential vaccine producer for the Balkan region.
    Published: September 2018
    Type: Article
  4. Improving vaccine coverage rates and vaccine acceptability in Serbia are critical issues. Locally made vaccines might be a part of the solution.
    Published: September 2018
    Type: Article
  5. This fact sheet describes a PATH project in Vietnam with support from the Biomedical Advanced Research and Development Authority within the US Department of Health and Human Services. The project supports the enhancement of sustainable influenza vaccine production in Vietnam. PATH is providing technical assistance to various groups in Vietnam to facilitate the production and clinical evaluation of safe and effective influenza vaccines and synergizing activities with work already under way in Vietnam through the World Health Organization.
    Published: September 2018
    Type: Resource Page
  6. This report describes the challenges, successes, and outcomes of a nine-year project to enhance sustainable seasonal and pandemic influenza vaccine development in low- and middle-income countries globally. PATH, in collaboration with the World Health Organization and the Biomedical Advanced Research and Development Authority within the US Department of Health and Human Services, provided technical support to vaccine manufacturers in Brazil, China, India, Serbia, Thailand, and Vietnam as they worked to develop, manufacture, and submit for licensure safe and effective influenza vaccines.
    Published: September 2018
    Type: Resource Page
  7. Vaccination is our best tool to fight influenza. At PATH, we're working with partners to develop a vaccine that covers all strains and lasts across seasons: a universal flu vaccine.
    Published: January 2018
    Type: Article
  8. PATH's use of advocacy to help stop outbreaks from becoming pandemics.
    Published: November 2017
    Type: Article
  9. Join us to defeat the next outbreak.
    Published: January 2017
    Type: Article
  10. This website about PATH’s Vietnam country program provides an overview of the program and its featured projects. See other PATH program websites.
    Published: January 2017
    Type: Resource Page
Load more